Prasugrel achieves greater inhibition of platelet aggregation and a lower rate of non-responders compared with clopidogrel in aspirin-treated patients with stable coronary artery disease.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples